List view / Grid view
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
3 June 2015 | By Victoria White
MSD has extended its existing collaborative research agreement with Agenus for the discovery and development of therapeutic antibodies...
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
3 June 2015 | By Victoria White
LDC and Qurient have signed a licence deal providing Qurient with exclusive worldwide rights to a series of highly-selective CDK7 inhibitors...
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
2 June 2015 | By Victoria White
MGB Biopharma has developed a stable IV formulation of MGB-BP-3 for the treatment of Gram-positive hospital-acquired infections...
2 June 2015 | By
Genticel has announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate...
1 June 2015 | By Victoria White
Engineers at MIT and the University of California at San Diego (UCSD) have devised a way to detect liver tumours, by enlisting the help of probiotics...
1 June 2015 | By Victoria White
Researchers analysing human aqueous humour samples have identified 763 proteins – including 386 proteins detected for the first time...
1 June 2015 | By Victoria White
AstraZeneca and Lilly have entered into a clinical trial collaboration to evaluate MEDI4736 in combination with ramucirumab in advanced solid tumours...
29 May 2015 | By Victoria White
Padlock Therapeutics has entered into an agreement to license intellectual property and a collection of assets targeted at PADs from GSK...
29 May 2015 | By Victoria White
Embera NeuroTherapeutics has announced that the first subject has received the initial dose in a Phase 1 clinical trial evaluating EMB-001...
29 May 2015 | By Victoria White
A team of researchers has found that the presence of IGFBP-1 interacted with MMP9 to promote breast cancer tumour formation in mouse models...
29 May 2015 | By Victoria White
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease, including early-onset Alzheimer's disease...
